DP VI Associates, L.P., 10% Owner at CADENCE PHARMACEUTICALS INC (CADX), sold 1,657 shares at $5.38 ($9K) on 2013-01-25, disclosed to the SEC on 2013-01-28.
Scheduled sale ($9k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.45 | 1,201 | $7K | 72.7% |
| 2 | $5.38 | 456 | $2K | 27.3% |
| Total | $5.43 avg | 1,657 | $9K | 100% |
| Filing → |
| CADX | SELL | 2013-01-30 | $6K | — | Filing → |
| ALIM | SELL | 2011-06-03 | $56K | — | Filing → |
| SOMX | SELL | 2006-12-22 | $87K | — | Filing → |